A Novel Approach to Early Phase Studies for Advanced Therapeutics

Screening & Recruiting Rare Disease Participants


Michael Murphy, MD, PhD | Derek Ansel

Have questions about how to conduct an early phase study in a patient population? You aren’t alone. Since our recent completion of an early phase study with rare disease patients, we have had numerous sponsors reach out to ask just that–“how did you do it?” So, we wrote a white paper.

Find out everything you need to know to run a successful Phase I patient study in this whitepaper.

Your form has been successfully submitted! Click the button below to access.
READ MORE
Michael Murphy, MD, PhD
MEET THE AUTHOR

Michael Murphy, MD, PhD

Chief Medical and Scientific Officer
LEARN MORE
Derek Ansel
MEET THE AUTHOR

Derek Ansel

Senior Director, Therapeutic Strategy Lead, Rare Diseases
LEARN MORE